Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

DERMAVANT SCI

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 74
  • 0 comments

FDA approve TAPINAROF

Comment Full text

PFIZER

  • FDA Approval
  • Dec. 13, 2024, 19:13 UTC
  • 76
  • 0 comments

FDA approve RIMEGEPANT SULFATE

Comment Full text

RISING

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 69
  • 0 comments

FDA approve CYTARABINE

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 69
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

APNAR PHARMA LP

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 68
  • 0 comments

FDA approve TERAZOSIN HYDROCHLORIDE

Comment Full text

ALEMBIC

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 69
  • 0 comments

FDA approve ACETAZOLAMIDE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 66
  • 0 comments

FDA approve GLUCAGON

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 49
  • 0 comments

FDA approve DIAZOXIDE

Comment Full text

SANDOZ

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 59
  • 0 comments

FDA approve ALLOPURINOL

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 13, 2024, 09:45 UTC
  • 72
  • 0 comments

FDA approve CYTARABINE

Comment Full text
  • Previous
  • 278
  • 279
  • 280
  • 281
  • 282
  • Next

Search

News categories

  • Technical Exchange News(11462)
  • Event(3236)
  • SEC News(211334)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136773)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin